Clinical trials
Terminated Phase 1 Hematologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 2 |
| Anaveon AG | 1 |
| Celgene | 1 |
| Celularity Incorporated | 1 |
| Fulcrum Therapeutics | 1 |
| GlaxoSmithKline | 1 |
| Gustavo Rivero | 1 |
| Protalex, Inc. | 1 |
| Taiho Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 10 |
| Multiple Myeloma | 3 |
| Neoplasms | 3 |
| Anemia, Sickle Cell | 2 |
| Leukemia | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Myelodysplastic Syndromes | 2 |
| Neoplasms, Plasma Cell | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.